ACADIA Pharmaceuticals Inc.
ACAD
$25.33
$0.803.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.14% | 14.69% | 213.87% | 150.27% | 2,897.22% |
| Total Depreciation and Amortization | 14.16% | -46.62% | 218.51% | 49.16% | 45.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.75% | -28.54% | -954.97% | 55.55% | -7.89% |
| Change in Net Operating Assets | 187.33% | -82.29% | 39.59% | 142.57% | -157.44% |
| Cash from Operations | 155.69% | -30.11% | -52.71% | 207.28% | 205.00% |
| Capital Expenditure | -- | -- | -- | -40.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.48% | -783.60% | -6,791.07% | -341.18% | 71.08% |
| Cash from Investing | 22.95% | -783.60% | 35,301.73% | -341.74% | 71.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 347.57% | 76.22% | -63.77% | -97.90% | -34.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 347.57% | 76.22% | -63.77% | -97.90% | -34.92% |
| Foreign Exchange rate Adjustments | 700.00% | -200.00% | -400.00% | -950.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.71% | -733.35% | 81.77% | -56.93% | 84.71% |